Recent Developments in Antimicrobial-Peptide-Conjugated Gold Nanoparticles.
暂无分享,去创建一个
[1] I. Toth,et al. Modern lipid‐, carbohydrate‐, and peptide‐based delivery systems for peptide, vaccine, and gene products , 2011, Medicinal research reviews.
[2] R. Stafford,et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[3] V. Manchanda,et al. Multidrug Resistant Acinetobacter , 2010, Journal of global infectious diseases.
[4] V. Vishwakarma,et al. Safety and Risk Associated with Nanoparticles - A Review , 2010 .
[5] Maria Luisa Mangoni,et al. Gold-nanoparticles coated with the antimicrobial peptide esculentin-1a(1-21)NH2 as a reliable strategy for antipseudomonal drugs. , 2017, Acta biomaterialia.
[6] S. Gambhir,et al. Noninvasive molecular imaging of small living subjects using Raman spectroscopy , 2008, Proceedings of the National Academy of Sciences.
[7] J. Vederas,et al. Synthesis and Structure − Activity Relationship Studies of N ‐ Terminal Analogues of the Antimicrobial Peptide Tridecaptin A 1 , 2014 .
[8] S. Assinder,et al. Mathematical model of β-lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released β-lactamases , 1996 .
[9] Younan Xia,et al. Gold Nanomaterials at Work in Biomedicine. , 2015, Chemical reviews.
[10] Katsumi Matsuzaki,et al. Control of cell selectivity of antimicrobial peptides. , 2009, Biochimica et biophysica acta.
[11] Dong Choon Hyun,et al. Engineered nanoparticles for drug delivery in cancer therapy. , 2014, Angewandte Chemie.
[12] Ildinete Silva-Pereira,et al. Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance , 2013, Front. Microbiol..
[13] Vladimir P Zharov,et al. Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles. , 2006, Biophysical journal.
[14] Jong-kook Lee,et al. Gold nanoparticle-DNA aptamer conjugate-assisted delivery of antimicrobial peptide effectively eliminates intracellular Salmonella enterica serovar Typhimurium. , 2016, Biomaterials.
[15] Kai Hilpert,et al. Synergistic Interaction between Silver Nanoparticles and Membrane-Permeabilizing Antimicrobial Peptides , 2009, Antimicrobial Agents and Chemotherapy.
[16] S. White,et al. 'Detergent-like' permeabilization of anionic lipid vesicles by melittin. , 2001, Biochimica et biophysica acta.
[17] V. Rotello,et al. Cell surface-based sensing with metallic nanoparticles. , 2015, Chemical Society reviews.
[18] P. Stewart,et al. Mechanisms of antibiotic resistance in bacterial biofilms. , 2002, International journal of medical microbiology : IJMM.
[19] Ali Akbar Pourfatollah,et al. Various methods of gold nanoparticles (GNPs) conjugation to antibodies , 2016 .
[20] W. D. de Jong,et al. Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.
[21] R. Hancock,et al. Biological Properties of Structurally Related α-Helical Cationic Antimicrobial Peptides , 1999, Infection and Immunity.
[22] M. Eblan,et al. Clinical Translation of Nanomedicine. , 2015, Chemical reviews.
[23] J. Odeberg,et al. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[24] U. Heinzmann,et al. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. , 2001, Environmental health perspectives.
[25] K. Brogden,et al. Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? , 2011, International journal of antimicrobial agents.
[26] R. Hancock,et al. Interaction of Cationic Peptides with Lipoteichoic Acid and Gram-Positive Bacteria , 1999, Infection and Immunity.
[27] T. Chakraborty,et al. Towards the synthesis of sugar amino acid containing antimicrobial noncytotoxic CAP conjugates with gold nanoparticles and a mechanistic study of cell disruption. , 2011, Organic & biomolecular chemistry.
[28] Francesco Stellacci,et al. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. , 2008, Nature materials.
[29] K. Lohner. New strategies for novel antibiotics: peptides targeting bacterial cell membranes. , 2009, General physiology and biophysics.
[30] Joel A. Swanson,et al. Shaping cups into phagosomes and macropinosomes , 2008, Nature Reviews Molecular Cell Biology.
[31] R. Shukla,et al. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[32] M. Zasloff,et al. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor , 1987 .
[33] L. Yang,et al. Barrel-stave model or toroidal model? A case study on melittin pores. , 2001, Biophysical journal.
[34] Liming Wang,et al. Cytotoxic Potential of Silver Nanoparticles , 2014, Yonsei medical journal.
[35] Peter Wipf,et al. Nanoparticles in cellular drug delivery. , 2009, Bioorganic & medicinal chemistry.
[36] Laetitia Gonzalez,et al. Genotoxicity of engineered nanomaterials: A critical review , 2008 .
[37] M. Casu,et al. Synthesis, characterization, antimicrobial activity and LPS-interaction properties of SB041, a novel dendrimeric peptide with antimicrobial properties , 2010, Peptides.
[38] B. Roelofsen,et al. The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. , 1973, Biochimica et biophysica acta.
[39] L. Shao,et al. The antimicrobial activity of nanoparticles: present situation and prospects for the future , 2017, International journal of nanomedicine.
[40] Vincent M Rotello,et al. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. , 2004, Bioconjugate chemistry.
[41] Sabine Neuss,et al. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. , 2009, Small.
[42] T. Miyata,et al. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. , 1988, The Journal of biological chemistry.
[43] Y. Shai,et al. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. , 1992, Biochemistry.
[44] K. Sokolov,et al. Two-photon luminescence imaging of cancer cells using molecularly targeted gold nanorods. , 2007, Nano letters.
[45] J. A. Salkeld,et al. Surface-attached cells, biofilms and biocide susceptibility: implications for hospital cleaning and disinfection. , 2015, The Journal of hospital infection.
[46] Chen Zhou,et al. Renal clearable inorganic nanoparticles: A new frontier of bionanotechnology , 2013 .
[47] I. Neundorf,et al. Design and Application of Antimicrobial Peptide Conjugates , 2016, International journal of molecular sciences.
[48] K. Ulbrich,et al. Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies. , 2016, Chemical reviews.
[49] H. Vogel,et al. The expanding scope of antimicrobial peptide structures and their modes of action. , 2011, Trends in biotechnology.
[50] Pawel L Urban,et al. Nanoparticles: their potential toxicity, waste and environmental management. , 2009, Waste management.
[51] A. Decho,et al. Inorganic nanoparticles engineered to attack bacteria. , 2015, Chemical Society reviews.
[52] Meng Wang,et al. Acute toxicity of nano- and micro-scale zinc powder in healthy adult mice. , 2006, Toxicology letters.
[53] Takuro Niidome,et al. PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[54] Gan-Moog Chow,et al. In vivo toxic studies and biodistribution of near infrared sensitive Au–Au2S nanoparticles as potential drug delivery carriers , 2008, Journal of materials science. Materials in medicine.
[55] S. Hua. Lipid-based nano-delivery systems for skin delivery of drugs and bioactives , 2015, Front. Pharmacol..
[56] S. Mitragotri,et al. Nanoparticles in the clinic , 2016, Bioengineering & translational medicine.
[57] L. Gentilucci,et al. Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. , 2010, Current pharmaceutical design.
[58] Y. Shai,et al. Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function. , 2000, Biochemistry.
[59] J. Reichert,et al. Future directions for peptide therapeutics development. , 2013, Drug discovery today.
[60] Xinyuan Zhu,et al. Phospholipid-assisted synthesis of size-controlled gold nanoparticles , 2007 .
[61] J. Rädler,et al. Controlled nanometric phase transitions of phospholipid membranes by plasmonic heating of single gold nanoparticles. , 2009, Nano letters.
[62] T. Ganz. Defensins: antimicrobial peptides of innate immunity , 2003, Nature Reviews Immunology.
[63] F. Masood,et al. Polymeric nanoparticles for targeted drug delivery system for cancer therapy. , 2016, Materials science & engineering. C, Materials for biological applications.
[64] Ameer Azam,et al. Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study , 2012, International journal of nanomedicine.
[65] Anirban Bhunia,et al. Enhanced stability and activity of an antimicrobial peptide in conjugation with silver nanoparticle. , 2016, Journal of colloid and interface science.
[66] H. G. Boman,et al. Ascaris nematodes from pig and human make three anti-bacterial peptides: isolation of cecropin P1 and two ASABF peptides , 2003, Cellular and Molecular Life Sciences CMLS.
[67] H Lecar,et al. Electrically gated ionic channels in lipid bilayers , 1977, Quarterly Reviews of Biophysics.
[68] Rodolfo Miranda,et al. Engineering Iron Oxide Nanoparticles for Clinical Settings , 2014, Nanobiomedicine.
[69] K. Rumbaugh,et al. One-step synthesis of high-density peptide-conjugated gold nanoparticles with antimicrobial efficacy in a systemic infection model. , 2016, Biomaterials.
[70] Ali Pourmand,et al. Current Opinion on Nanotoxicology , 2012, DARU Journal of Pharmaceutical Sciences.
[71] Chun-Ming Huang,et al. Use of nanoparticles as therapy for methicillin-resistant Staphylococcus aureus infections. , 2009, Current drug metabolism.
[72] Dakrong Pissuwan,et al. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[73] Ekambaram Perumal,et al. Metal oxide nanoparticles as antimicrobial agents: a promise for the future. , 2017, International journal of antimicrobial agents.
[74] M. Marahiel,et al. The Structural Diversity of Acidic Lipopeptide Antibiotics , 2009, Chembiochem : a European journal of chemical biology.
[75] Michael R. Yeaman,et al. Mechanisms of Antimicrobial Peptide Action and Resistance , 2003, Pharmacological Reviews.
[76] A. Ulrich,et al. Antibiotic gold: tethering of antimicrobial peptides to gold nanoparticles maintains conformational flexibility of peptides and improves trypsin susceptibility. , 2017, Biomaterials science.
[77] Y. Shai,et al. Mode of action of linear amphipathic α-helical antimicrobial peptides , 1998 .
[78] J. Hamilton-miller,et al. Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. , 1992, The Journal of antimicrobial chemotherapy.
[79] Yingge Zhang,et al. The application of carbon nanotubes in target drug delivery systems for cancer therapies , 2011, Nanoscale research letters.
[80] Hongbin Li,et al. Quantifying thiol–gold interactions towards the efficient strength control , 2014, Nature Communications.
[81] Thomas Bjarnsholt,et al. Antibiotic resistance of bacterial biofilms. , 2010, International journal of antimicrobial agents.
[82] R. Hancock,et al. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.
[83] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[84] I. Sutherland,et al. The biofilm matrix--an immobilized but dynamic microbial environment. , 2001, Trends in microbiology.
[85] Dar-Bin Shieh,et al. Nanoshell Magnetic Resonance Imaging Contrast Agents , 2007, 2007 Digest of papers Microprocesses and Nanotechnology.
[86] W. Chan,et al. DNA assembly of nanoparticle superstructures for controlled biological delivery and elimination , 2014, Nature nanotechnology.
[87] Hui Zhang,et al. Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. , 2007, Nano letters.
[88] D. Dunn,et al. Bacterial membrane disrupting dodecapeptide SC4 improves survival of mice challenged with Pseudomonas aeruginosa. , 2013, Biochimica et biophysica acta.
[89] B. Bechinger,et al. The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy. , 1999, Biochimica et biophysica acta.
[90] O. Shamova,et al. Synthesis and study of antimicrobial activity of bioconjugates of silver nanoparticles and endogenous antibiotics , 2011 .
[91] A. Brandelli. Nanostructures as promising tools for delivery of antimicrobial peptides. , 2012, Mini reviews in medicinal chemistry.
[92] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[93] Jennifer K Barton,et al. Biodegradable Plasmon Resonant Nanoshells , 2008, Advanced materials.
[94] Meng Wang,et al. Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats. , 2008, Toxicology.
[95] K. Lewis,et al. Riddle of Biofilm Resistance , 2001, Antimicrobial Agents and Chemotherapy.
[96] M. Zasloff,et al. Magainins: a new family of membrane-active host defense peptides. , 1990, Biochemical pharmacology.
[97] Y. Shai,et al. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. , 1999, Biochimica et biophysica acta.
[98] Xiangfang Zeng,et al. Antimicrobial Peptides as Potential Alternatives to Antibiotics in Food Animal Industry , 2016, International journal of molecular sciences.
[99] Xingyu Jiang,et al. Small molecule-capped gold nanoparticles as potent antibacterial agents that target Gram-negative bacteria. , 2010, Journal of the American Chemical Society.
[100] N. Fujii,et al. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. , 1996, Biochemistry.
[101] W. H. Lewis. Pinocytosis by Malignant Cells , 1937 .
[102] R. Hancock,et al. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. , 2006, Current opinion in pharmacology.
[103] Morteza Mahmoudi,et al. Antibacterial properties of nanoparticles. , 2012, Trends in biotechnology.
[104] H. Vogel,et al. Diversity of antimicrobial peptides and their mechanisms of action. , 1999, Biochimica et biophysica acta.
[105] Brian F. G. Johnson,et al. Selective oxidation with dioxygen by gold nanoparticle catalysts derived from 55-atom clusters , 2008, Nature.
[106] T. Hoffmann,et al. Peptide therapeutics: current status and future directions. , 2015, Drug discovery today.
[107] P. Couvreur,et al. Peptide conjugation: before or after nanoparticle formation? , 2014, Bioconjugate chemistry.
[108] Avinash Sonawane,et al. Cationic Antimicrobial Peptides and Biogenic Silver Nanoparticles Kill Mycobacteria without Eliciting DNA Damage and Cytotoxicity in Mouse Macrophages , 2013, Antimicrobial Agents and Chemotherapy.
[109] K. Matsuzaki. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. , 1999, Biochimica et biophysica acta.
[110] V. Torchilin,et al. Multifunctional polymeric micelles for delivery of drugs and siRNA , 2014, Front. Pharmacol..
[111] Liangfang Zhang,et al. Nanoparticle approaches against bacterial infections. , 2014, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[112] Yi Wang,et al. A label-free biosensor based on gold nanoshell monolayers for monitoring biomolecular interactions in diluted whole blood. , 2008, Biosensors & bioelectronics.
[113] R. Lehrer,et al. Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins , 1993, FEBS letters.
[114] Thomas Kelly,et al. Synergistic enhancement of selective nanophotothermolysis with gold nanoclusters: Potential for cancer therapy , 2005, Lasers in surgery and medicine.
[115] Seungpyo Hong,et al. Cationic nanoparticles induce nanoscale disruption in living cell plasma membranes. , 2009, The journal of physical chemistry. B.
[116] Tom P. Carberry,et al. Dendrimers functionalized with membrane-interacting peptides for viral inhibition , 2013, International journal of nanomedicine.
[117] C. R. Martin,et al. Carbon nanotubule membranes for electrochemical energy storage and production , 1998, Nature.
[118] Paul Stoodley,et al. Bacterial biofilms: from the Natural environment to infectious diseases , 2004, Nature Reviews Microbiology.
[119] Arie V. Nieuw Amerongen,et al. Antimicrobial Peptides: Properties and Applicability , 2001, Biological chemistry.
[120] L. Mortelmans,et al. Passage of Inhaled Particles Into the Blood Circulation in Humans , 2002, Circulation.
[121] Maureen A Walling,et al. Quantum Dots for Live Cell and In Vivo Imaging , 2009, International journal of molecular sciences.
[122] M. Vaara. Polymyxins and their novel derivatives. , 2010, Current opinion in microbiology.
[123] R. Hancock,et al. Mode of Action of the Antimicrobial Peptide Indolicidin* , 1996, The Journal of Biological Chemistry.
[124] K. Hahm,et al. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. , 2005, Biochemistry.
[125] R. Epand,et al. Lipid domains in bacterial membranes and the action of antimicrobial agents. , 2009, Biochimica et biophysica acta.
[126] Vincent M Rotello,et al. Gold nanoparticles in delivery applications. , 2008, Advanced drug delivery reviews.
[127] Jean-François Lutz,et al. Efficient construction of therapeutics, bioconjugates, biomaterials and bioactive surfaces using azide-alkyne "click" chemistry. , 2008, Advanced drug delivery reviews.
[128] Yibing Huang,et al. Role of helicity of α-helical antimicrobial peptides to improve specificity , 2014, Protein & Cell.
[129] David B Resnik,et al. Ethics in nanomedicine. , 2007, Nanomedicine.
[130] I. Chopra,et al. The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? , 2007, The Journal of antimicrobial chemotherapy.
[131] Ji-Xin Cheng,et al. Gold Nanorods Mediate Tumor Cell Death by Compromising Membrane Integrity , 2007, Advanced materials.
[132] C. Suri,et al. Interaction of gold nanoparticles with protein: A spectroscopic study to monitor protein conformational changes , 2008 .
[133] V. Torchilin. Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.
[134] S. Pinto,et al. High-density antimicrobial peptide coating with broad activity and low cytotoxicity against human cells. , 2016, Acta biomaterialia.
[135] M. Marahiel,et al. Daptomycin, a Bacterial Lipopeptide Synthesized by a Nonribosomal Machinery* , 2010, The Journal of Biological Chemistry.
[136] K. Brogden. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.
[137] M. Przybylski,et al. Amino acid sequences of two proline-rich bactenecins. Antimicrobial peptides of bovine neutrophils. , 1990, The Journal of biological chemistry.
[138] Itamar Willner,et al. Integrated nanoparticle-biomolecule hybrid systems: synthesis, properties, and applications. , 2004, Angewandte Chemie.
[139] J. Hainfeld,et al. The use of gold nanoparticles to enhance radiotherapy in mice. , 2004, Physics in medicine and biology.
[140] Nastassja A. Lewinski,et al. Cytotoxicity of nanoparticles. , 2008, Small.
[141] Jianping Xie,et al. The potent antimicrobial properties of cell penetrating peptide-conjugated silver nanoparticles with excellent selectivity for gram-positive bacteria over erythrocytes. , 2013, Nanoscale.
[142] Olivier Taboureau,et al. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus , 2005, Nature.
[143] R. Landmann,et al. Silver Coordination Polymers for Prevention of Implant Infection: Thiol Interaction, Impact on Respiratory Chain Enzymes, and Hydroxyl Radical Induction , 2010, Antimicrobial Agents and Chemotherapy.
[144] D. Astruc,et al. The copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) “click” reaction and its applications. An overview , 2011 .
[145] Keerti Jain,et al. Dendrimer as nanocarrier for drug delivery , 2014 .
[146] A. Obwegeser,et al. Silver segregation and bacterial growth of intraventricular catheters impregnated with silver nanoparticles in cerebrospinal fluid drainages , 2008, Neurological research.
[147] K. Gaus,et al. Synthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry. , 2009, Future medicinal chemistry.
[148] Christopher J. White,et al. Contemporary strategies for peptide macrocyclization. , 2011, Nature chemistry.
[149] Anjan Kr Dasgupta,et al. Cell selective response to gold nanoparticles. , 2007, Nanomedicine : nanotechnology, biology, and medicine.
[150] Ramasamy Venkatesan,et al. Vancomycin bound biogenic gold nanoparticles: A different perspective for development of anti VRSA agents , 2011 .
[151] Craig A. Grimes,et al. A review on highly ordered, vertically oriented TiO2 nanotube arrays: Fabrication, material properties, and solar energy applications , 2006 .
[152] Yehuda Carmeli,et al. Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact , 2006, Antimicrobial Agents and Chemotherapy.
[153] Bing Xu,et al. Presenting Vancomycin on Nanoparticles to Enhance Antimicrobial Activities , 2003 .
[154] Jianqing Gao,et al. Integration of antimicrobial peptides with gold nanoparticles as unique non-viral vectors for gene delivery to mesenchymal stem cells with antibacterial activity. , 2016, Biomaterials.
[155] C. Murphy,et al. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.
[156] Y. Shai,et al. Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. , 1997, Biochemistry.
[157] Aswathy Ravindran,et al. Biofunctionalized silver nanoparticles: advances and prospects. , 2013, Colloids and surfaces. B, Biointerfaces.
[158] Miriam Rafailovich,et al. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents , 2011, Expert review of anti-infective therapy.
[159] David Brown,et al. The pulmonary toxicology of ultrafine particles. , 2002, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[160] R. Vitorino,et al. Antimicrobial peptides: an alternative for innovative medicines? , 2015, Applied Microbiology and Biotechnology.
[161] Agnes G Oomen,et al. What do we (need to) know about the kinetic properties of nanoparticles in the body? , 2007, Regulatory toxicology and pharmacology : RTP.
[162] C. Niemeyer. REVIEW Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science , 2022 .
[163] Wei-Yu Chen,et al. Potent antibacterial nanoparticles for pathogenic bacteria. , 2015, ACS applied materials & interfaces.
[164] Y. Barenholz. Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[165] Chuanqi Peng,et al. Tailoring Renal Clearance and Tumor Targeting of Ultrasmall Metal Nanoparticles with Particle Density. , 2016, Angewandte Chemie.
[166] Catherine J. Murphy,et al. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? , 2010, Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology.
[167] Hongtao Yu,et al. Mechanisms of nanotoxicity: Generation of reactive oxygen species , 2014, Journal of food and drug analysis.
[168] Bong‐Jin Lee,et al. Antimicrobial peptides: therapeutic potentials , 2014, Expert review of anti-infective therapy.
[169] Ling Yang,et al. Particle surface characteristics may play an important role in phytotoxicity of alumina nanoparticles. , 2005, Toxicology letters.
[170] M Laird Forrest,et al. Clinical toxicities of nanocarrier systems. , 2008, Advanced drug delivery reviews.
[171] Wei Qian,et al. Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp, and polarized surface Raman spectra: a potential cancer diagnostic marker. , 2007, Nano letters.
[172] K. Meng,et al. Eukaryotic expression and antimicrobial spectrum determination of the peptide tachyplesin II. , 2008, Protein expression and purification.
[173] M. Abdollahi,et al. Different biokinetics of nanomedicines linking to their toxicity; an overview , 2013, DARU Journal of Pharmaceutical Sciences.
[174] Frances Separovic,et al. The antimicrobial peptide aurein 1.2 disrupts model membranes via the carpet mechanism. , 2012, Physical chemistry chemical physics : PCCP.
[175] Yoonkyung Park,et al. Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties , 2015, Amino Acids.
[176] Wenjing Zhang,et al. Bacitracin-conjugated superparamagnetic iron oxide nanoparticles: synthesis, characterization and antibacterial activity. , 2012, Chemphyschem : a European journal of chemical physics and physical chemistry.
[177] A. Cameron,et al. Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides. , 2015, Journal of medicinal chemistry.
[178] Young Jik Kwon,et al. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[179] J. Vederas,et al. Synthesis of Tridecaptin-Antibiotic Conjugates with in Vivo Activity against Gram-Negative Bacteria. , 2015, Journal of medicinal chemistry.
[180] C. Ricci,et al. Antimicrobial Activity of Novel Dendrimeric Peptides Obtained by Phage Display Selection and Rational Modification , 2005, Antimicrobial Agents and Chemotherapy.
[181] F. Tielens,et al. AuS and SH Bond Formation/Breaking during the Formation of Alkanethiol SAMs on Au(111): A Theoretical Study , 2010 .
[182] C. Deber,et al. Basis for Selectivity of Cationic Antimicrobial Peptides for Bacterial Versus Mammalian Membranes* , 2005, Journal of Biological Chemistry.
[183] Vincent M. Rotello,et al. Applications of Nanoparticles in Biology , 2008 .
[184] Kenneth Vecchio,et al. Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. , 2011, Journal of the American Chemical Society.
[185] M. Veerapandian,et al. Functionalization of biomolecules on nanoparticles: specialized for antibacterial applications , 2011, Applied Microbiology and Biotechnology.
[186] K. Hahm,et al. Cell selectivity of an antimicrobial peptide melittin diastereomer with D-amino acid in the leucine zipper sequence. , 2007, Journal of biochemistry and molecular biology.
[187] Asad U. Khan,et al. Nanoparticles vs. biofilms: a battle against another paradigm of antibiotic resistance , 2016 .
[188] P. Cullis,et al. Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.
[189] A. Thayer. IMPROVING PEPTIDES: Small firms develop better PEPTIDE DRUG CANDIDATES to expand this pharmaceutical class and attract big pharma partners , 2011 .